Pro Claims In Orphan Medicines Approved By the European Medicines Agency (Ema) for the Treatment of Lymphoproliferative Disorders.
Value in health : the journal of the…
View on PubMed
Sorry, we couldn't extract any citations for this paper.
Sorry, we couldn't extract any references for this paper.
Loading similar papers…
Presentations referencing similar topics
Title : Personalized genetic medicines for inherited disorders
Steve Wilton • Sep 28, 2017
Genetic analysis of lymphoproliferative disorders Standardisation of bone marrow staging
Nicholas Grigoropoulos • Oct 27, 2017
Acid Base Disorders in Medicine
Marc A. Pohl • Aug 27, 2017